Patent · US Active

Treating or preventing adverse liver conditions

US11771737B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Tim Greten · Baltimore, US
Chi Him Eddie Ma · Hong Kong, CN

Key dates

Filing date	Oct 29, 2018
Grant date	Oct 3, 2023
Priority date	—
Expiry date	Jan 1, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

In embodiments, the invention provides a method of treating or preventing an adverse condition of the liver of a mammal, the method comprising administering to the mammal an effective amount of vancomycin and a checkpoint inhibitor. In embodiments, the invention provides a method of treating or preventing an adverse condition of the liver of a mammal, the method comprising administering to the mammal an effective amount of a primary bile acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.